Cardio-adipose tissue cross-talk: Relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure

European Journal of Heart Failure

Volumn 16, Issue 6, 2014, Pages 633-638

  Lindberg, Søren ^a,b   Jensen, Jan Skov ^a,b,c   Bjerre, Mette ^d   Pedersen, Sune H ^a,b   Frystyk, Jan ^d,e   Flyvbjerg, Allan ^d,e   Mogelvang, Rasmus ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adiponectin; Heart failure; HF; ProBNP

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN; LIPID; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; LIPID METABOLISM; MALE; PHYSICAL ACTIVITY; POPULATION; POPULATION RISK; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; BLOOD; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84901978564     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.82     Document Type: Article

References (33)

1. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA,. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-1677.
2. Stanek B, Frey B, Hulsmann M, Berger R, Sturm B, Strametz-Juranek J, Bergler-Klein J, Moser P, Bojic A, Hartter E, Pacher R,. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 436-442. (Pubitemid 32721772)
3. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, Horie M,. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 2007; 28: 1723-1730. (Pubitemid 47227093)
4. Costello-Boerrigter LC, Burnett JC Jr,. A new role for the natriuretic peptides: metabolic regulators of the adipocyte. J Am Coll Cardiol 2009; 53: 2078-2079.
5. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K,. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792. (Pubitemid 44033298)
6. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, McMurray JJ,. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007; 28: 829-835. (Pubitemid 47343601)
7. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT,. Higher Natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol 2013; 62: 752-760.
8. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J,. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008; 19: 130-137. (Pubitemid 351608304)
9. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M,. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009; 53: 2070-2077.
10. Ohara T, Kim J, Asakura M, Asanuma H, Nakatani S, Hashimura K, Kanzaki H, Funahashi T, Tomoike H, Kitakaze M,. Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects. Hypertens Res 2008; 31: 825-8231.
11. Mogelvang R, Goetze JP, Schnohr P, Lange P, Sogaard P, Rehfeld JF, Jensen JS,. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 2007; 50: 1694-1701. (Pubitemid 47562682)
12. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M,. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56: 124-130. (Pubitemid 36315938)
13. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A,. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005; 48: 1911-1918. (Pubitemid 41317848)
14. Vervoort G, Klein Gunnewiek JM, Willems HL, Wetzels JF,. Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR. Nephrol Dial Transplant 2006; 21: 2998-2999. (Pubitemid 44542279)
15. Lindberg S, Mogelvang R, Pedersen SH, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Jensen JS,. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol 2013; 111: 1139-1145.
16. Haugen E, Furukawa Y, Isic A, Fu M,. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 2008; 125: 216-219.
17. Takano H, Obata JE, Kodama Y, Kitta Y, Nakamura T, Mende A, Kawabata K, Saito Y, Fujioka D, Kobayashi T, Yano T, Sano K, Kugiyama K,. Adiponectin is released from the heart in patients with heart failure. Int J Cardiol 2009; 132: 221-226.
18. Tang WH, Shrestha K, Tong W, Wang Z, Troughton RW, Borowski AG, Klein AL, Hazen SL,. Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Transl Res 2013; 162: 26-33.
19. Laoutaris ID, Vasiliadis IK, Dritsas A, Mavrogeni S, Kallistratos MS, Manginas A, Chaidaroglou A, Degiannis D, Panagiotakos DB, Cokkinos DV,. High plasma adiponectin is related to low functional capacity in patients with chronic heart failure. Int J Cardiol 2010; 144: 230-231.
20. Yin WH, Wei J, Huang WP, Chen JW, Young MS, Lin SJ,. Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure. Circ J 2012; 76: 2139-2147.
21. Wannamethee SG, Welsh P, Whincup PH, Sawar N, Thomas MC, Gudnarsson V, Sattar N,. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 2011; 18: 65-71.
22. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T,. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 2007; 71: 623-630. (Pubitemid 46683348)
23. Van Berendoncks AM, Beckers P, Hoymans VY, Possemiers N, Coenen S, Elseviers MM, Vrints CJ, Conraads VM,. beta-blockers modify the prognostic value of adiponectin in chronic heart failure. Int J Cardiol 2011; 150: 296-300.
24. Kalra PR, Tigas S,. Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol 2002; 85: 125-132.
25. Engeli S, Birkenfeld AL, Badin PM, Bourlier V, Louche K, Viguerie N, Thalamas C, Montastier E, Larrouy D, Harant I, de Glisezinski I, Lieske S, Reinke J, Beckmann B, Langin D, Jordan J, Moro C,. Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J Clin Invest 2012; 122: 4675-4679.
26. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S,. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012; 122: 1022-1036.
27. Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Horie M,. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail 2008; 10: 360-366.
28. Birkenfeld AL, Boschmann M, Engeli S, Moro C, Arafat AM, Luft FC, Jordan J,. Atrial natriuretic peptide and adiponectin interactions in man. PLoS One 2012; 7: e43238.
29. Souza SC, Chau MD, Yang Q, Gauthier MS, Clairmont KB, Wu Z, Gromada J, Dole WP,. Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK. Biochem Biophys Res Commun 2011; 410: 398-403.
30. Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B,. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 2008; 158: 179-187. (Pubitemid 351298534)
31. Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH,. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009; 103: 1411-1416.
32. Jandeleit-Dahm KA,. Dual ACE/NEP inhibitors-more than playing the ACE card. J Hum Hypertens 2006; 20: 478-481. (Pubitemid 43923116)
33. Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A,. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab 2007; 92: 1857-1862. (Pubitemid 46997200)